文献速递哮喘

哮喘气道重塑与上皮:新时代前沿

Airway remodelling in asthma and the epithelium: on the edge of a new era.
PubMed 文献 · Eur Respir J · 2024-04-18

该综述聚焦哮喘气道重塑中气道上皮的作用。环境刺激可经上皮炎症级联反应启动重塑,涉及胸腺基质淋巴细胞生成素、IL-33和IL-25等上皮细胞因子;上皮也可不依赖炎症、在支气管收缩的机械应力下启动重塑。遗传与表观遗传改变影响重塑,靶向上皮及上皮细胞因子的治疗可能修饰重塑。

要点

  • 上皮细胞因子TSLP、IL-33和IL-25介导上皮与成纤维细胞、肥大细胞与气道平滑肌细胞及免疫细胞间交互促进重塑。
  • 支气管收缩时的机械应力可使上皮不依赖炎症启动气道重塑。
  • 遗传与表观遗传改变影响上皮组分并参与重塑调控。

核心结论

  • 上皮及上皮细胞因子是驱动哮喘气道重塑的关键环节,靶向上皮有望修饰重塑。

研究设计与样本

  • 综述,总结基因测序与成像技术进展下上皮及上皮细胞因子驱动气道重塑的研究进展。

主要发现

  • 环境刺激经上皮启动炎症级联,涉及TSLP、IL-33和IL-25等介质并作用于结构细胞与免疫细胞。
  • 上皮可通过上皮细胞与成纤维细胞、肥大细胞与气道平滑肌细胞间交互及与巨噬细胞等免疫细胞信号传导促进重塑。
  • 支气管收缩时的机械应力可使上皮不依赖炎症启动气道重塑。
  • 遗传与表观遗传改变被认为影响上皮组分并影响重塑。

关键数值与推荐

  • 上皮细胞因子包括胸腺基质淋巴细胞生成素、IL-33和IL-25。

临床怎么用

  • 关注靶向上皮及上皮细胞因子的治疗对气道重塑的潜在修饰作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Asthma is a chronic, heterogeneous disease of the airways, often characterised by structural changes known collectively as airway remodelling. In response to environmental insults, including pathogens, allergens and pollutants, the epithelium can initiate remodelling via an inflammatory cascade involving a variety of mediators that have downstream effects on both structural and immune cells. These mediators include the epithelial cytokines thymic stromal lymphopoietin, interleukin (IL)-33 and IL-25, which facilitate airway remodelling through cross-talk between epithelial cells and fibroblasts, and between mast cells and airway smooth muscle cells, as well as through signalling with immune cells such as macrophages. The epithelium can also initiate airway remodelling independently of inflammation in response to the mechanical stress present during bronchoconstriction. Furthermore, genetic and epigenetic alterations to epithelial components are believed to influence remodelling. Here, we review recent advances in our understanding of the roles of the epithelium and epithelial cytokines in driving airway remodelling, facilitated by developments in genetic sequencing and imaging techniques. We also explore how new and existing therapeutics that target the epithelium and epithelial cytokines could modify airway remodelling.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Varricchi G, Brightling CE, Grainge C, et al. Airway remodelling in asthma and the epithelium: on the edge of a new era. Eur Respir J. 2024. PMID: 38609094. doi:10.1183/13993003.01619-2023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。